Edwards Lifesciences Corp (EW) Stock Analysis

Sector: HEALTHCARE - MEDICAL DEVICES

Exchange: NYSE

Key Metrics

• Price: $85.89
• Market Cap: $48.96B
• P/E Ratio: 46.08
• EPS: $1.81
• 52-Week High: $87.89
• 52-Week Low: $65.94

Market Sentiment

Edwards Lifesciences Corp currently has a Bullish sentiment score of 0.17.

About Edwards Lifesciences Corp

Edwards Lifesciences Corp is a prominent American medical technology firm headquartered in Irvine, California, specializing in heart valve therapies and hemodynamic monitoring. Renowned for its innovative transcatheter heart valve technologies, the company is dedicated to developing advanced solutions for patients with heart diseases, ultimately aiming to enhance clinical outcomes and improve patient quality of life. With a strong market presence and a pipeline rich in cutting-edge products, ...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Edwards Lifesciences Corp and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does EW pay dividends?

Edwards Lifesciences Corp (EW) does not currently pay a regular dividend.

What is EW's P/E ratio?

Edwards Lifesciences Corp has a price-to-earnings (P/E) ratio of 46.08.

What is EW's market cap?

Edwards Lifesciences Corp (EW) has a market capitalization of $48.96B with a current stock price of $85.89.